Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation

NCT02459574 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02459574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02459574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2015
Completion date
November 27, 2018
Enrollment
321 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, recurrent atrial fibrillation